Personal information

Countries

Greece

Activities

Collapse all

Employment (2)

Mediterraneo Hospital: Athens, Attike, GR

(Headache Clinic)
Employment
Source: Self-asserted source
Michail Vikelis

Glyfada Headache Clinic: Glyfada, GR

Employment
Source: Self-asserted source
Michail Vikelis

Education and qualifications (3)

Università degli Studi di Roma La Sapienza: Roma, Lazio, IT

MSc in Headache Medicine
Education
Source: Self-asserted source
Michail Vikelis

National and Kapodistrian University of Athens - Faculty of Medicine: Athens, GR

MD
Education
Source: Self-asserted source
Michail Vikelis

National and Kapodistrian University of Athens - Faculty of Medicine: Athens, GR

PhD
Education
Source: Self-asserted source
Michail Vikelis

Works (49)

Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study

Brain Sciences
2024-11-22 | Journal article
DOI: 10.3390/brainsci14121169
Contributors: Emmanouil V. Dermitzakis; Dimitrios Rikos; Michail Vikelis; Georgia Xiromerisiou; Styliani Zisopoulou; Dimitrios Rallis; Panagiotis Soldatos; George S. Vlachos; Georgios G. Vasiliadis; Andreas A. Argyriou
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints

Expert Review of Neurotherapeutics
2024-08-02 | Journal article
DOI: 10.1080/14737175.2024.2365312
Contributors: Michail Vikelis; Dimitrios Rikos; Andreas A. Argyriou; Pinelopi Papachristou; Dimitrios Rallis; Theodoros Karapanayiotides; Andreas Galanopoulos; Konstantinos Spingos; Nikolaos Dimisianos; Emmanouil Giakoumakis et al.
Source: check_circle
Crossref

Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options

Journal of Clinical Medicine
2024-05-08 | Journal article
DOI: 10.3390/jcm13102768
Contributors: Emmanouil V. Dermitzakis; Andreas A. Argyriou; Konstantinos Bilias; Evangelia Barmpa; Sofia Liapi; Dimitrios Rikos; Georgia Xiromerisiou; Panagiotis Soldatos; Michail Vikelis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review

Journal of Clinical Medicine
2024-03-28 | Journal article
DOI: 10.3390/jcm13071964
Contributors: Dimitrios Rikos; Michail Vikelis; Emmanouil V. Dermitzakis; Panagiotis Soldatos; Dimitrios Rallis; Jobst Rudolf; Anna P. Andreou; Andreas A. Argyriou
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine

Toxins
2024-02-15 | Journal article
DOI: 10.3390/toxins16020106
Contributors: Andreas A. Argyriou; Emmanouil V. Dermitzakis; Dimitrios Rikos; Georgia Xiromerisiou; Panagiotis Soldatos; Pantelis Litsardopoulos; Michail Vikelis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine

Journal of Clinical Medicine
2024-01-10 | Journal article
DOI: 10.3390/jcm13020386
Contributors: Emmanouil V. Dermitzakis; Michail Vikelis; Georgia Xiromerisiou; Dimitrios Rallis; Panagiotis Soldatos; Pantelis Litsardopoulos; Dimitrios Rikos; Andreas A. Argyriou
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control Study

Neurology International
2023-09-05 | Journal article
DOI: 10.3390/neurolint15030069
Contributors: Maria Papasavva; Michail Vikelis; Vasileios Siokas; Martha-Spyridoula Katsarou; Emmanouil V. Dermitzakis; Athanasios Raptis; Efthimios Dardiotis; Nikolaos Drakoulis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up

Toxins
2023-08-31 | Journal article
DOI: 10.3390/toxins15090539
Contributors: Georgia Xiromerisiou; Ioannis C. Lampropoulos; Emmanouil V. Dermitzakis; Michail Vikelis; Chrysoula Marogianni; Dimitris Mysiris; Andreas A. Argyriou
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry

Journal of Clinical Medicine
2023-07-06 | Journal article
DOI: 10.3390/jcm12134526
Contributors: Michail Vikelis; Emmanouil V. Dermitzakis; Georgia Xiromerisiou; Dimitrios Rallis; Panagiotis Soldatos; Pantelis Litsardopoulos; Dimitrios Rikos; Andreas A. Argyriou
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry

Journal of Clinical Medicine
2023-04-29 | Journal article
DOI: 10.3390/jcm12093218
Contributors: Andreas A. Argyriou; Emmanouil V. Dermitzakis; Georgia Xiromerisiou; Dimitrios Rallis; Panagiotis Soldatos; Pantelis Litsardopoulos; Michail Vikelis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases

Medicina
2023-04-09 | Journal article
DOI: 10.3390/medicina59040734
Contributors: Michail Vikelis; Andreas A. Argyriou; Anastasia Antoniou; Konstantinos C. Spingos; Athanasios E. Skliros; Konstantinos Bilias; Aikaterini Kouroudi; Emmanouil V. Dermitzakis; Efstathios A. Skliros
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine

Toxins
2022-12-02 | Journal article
DOI: 10.3390/toxins14120847
Contributors: Andreas A. Argyriou; Emmanouil V. Dermitzakis; Georgia Xiromerisiou; Michail Vikelis
Source: check_circle
Crossref

Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic Migraine

Toxins
2022-06-24 | Journal article
DOI: 10.3390/toxins14070434
Contributors: Emmanouil V. Dermitzakis; Michail Vikelis; George S. Vlachos; Andreas A. Argyriou
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis

Toxins
2022-04-21 | Journal article
DOI: 10.3390/toxins14050296
Contributors: Emmanouil V. Dermitzakis; Michail Vikelis; George S. Vlachos; Andreas A. Argyriou
Source: check_circle
Crossref

Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis

Journal of Clinical Medicine
2020-12-27 | Journal article
DOI: 10.3390/jcm10010067
Contributors: Michail Vikelis; Emmanouil V. Dermitzakis; George S. Vlachos; Panagiotis Soldatos; Konstantinos C. Spingos; Pantelis Litsardopoulos; Evangelia Kararizou; Andreas A. Argyriou
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Real world, open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 (Vivinor®) for episodic migraine prophylaxis

2020-08-03 | Other
DOI: 10.21203/rs.3.rs-50685/v1
Contributors: Michail Vikelis; Emmanouil V. Dermitzakis; Georgios S. Vlachos; Panagiotis Soldatos; Konstantinos C. Spingos; Pantelis Litsardopoulos; Evangelia Kararizou; Andreas A. Argyriou
Source: check_circle
Crossref

Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis.

Headache
2020-04 | Journal article
DOI: 10.1111/head.13828
PMID: 32352572
Contributors: Liampas I; Siokas V; Brotis A; Vikelis M; Dardiotis E
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population.

Journal of molecular neuroscience : MN
2019-11 | Journal article
DOI: 10.1007/s12031-019-01439-0
PMID: 31768945
Contributors: Papasavva M; Katsarou MS; Vikelis M; Mitropoulou E; Dermitzakis EV; Papakonstantinou S; Arvaniti C; Mitsikostas DD; Gozes I; Tsatsakis AM et al.
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Acute aseptic meningitis during isotretinoin treatment for nodular acne solely presenting with headache: case report and brief review of the literature.

The International journal of neuroscience
2018-10 | Journal article
DOI: 10.1080/00207454.2018.1517763
PMID: 30160569
Contributors: Chalimou I; Krilis A; Anastopoulou GG; Braun H; Vikelis M; Makridou A; Makris N; Argyriou AA
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment.

The journal of headache and pain
2018-09 | Journal article
DOI: 10.1186/s10194-018-0918-3
PMID: 30225735
PMC: PMC6755578
Contributors: Vikelis M; Argyriou AA; Dermitzakis EV; Spingos KC; Makris N; Kararizou E
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

A new era in headache treatment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2018-06 | Journal article
DOI: 10.1007/s10072-018-3337-y
PMID: 29904827
Contributors: Vikelis M; Spingos KC; Rapoport AM
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire.

PharmacoEconomics - open
2018-03 | Journal article
DOI: 10.1007/s41669-017-0034-3
PMID: 29464670
PMC: PMC5820235
Contributors: Oikonomidi T; Vikelis M; Artemiadis A; Chrousos GP; Darviri C
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Patients' preferences for headache acute and preventive treatment.

The journal of headache and pain
2017-10 | Journal article
DOI: 10.1186/s10194-017-0813-3
PMID: 28986900
PMC: PMC5630539
Contributors: Mitsikostas DD; Belesioti I; Arvaniti C; Mitropoulou E; Deligianni C; Kasioti E; Constantinidis T; Dermitzakis M; Vikelis M; Hellenic Headache Society
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study.

BMC neurology
2017-05 | Journal article
DOI: 10.1186/s12883-017-0869-3
PMID: 28521762
PMC: PMC5437420
Contributors: Vikelis M; Dermitzakis EV; Spingos KC; Vasiliadis GG; Vlachos GS; Kararizou E
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Cluster headache in Greece: an observational clinical and demographic study of 302 patients.

The journal of headache and pain
2016-09 | Journal article
DOI: 10.1186/s10194-016-0683-0
PMID: 27670427
PMC: PMC5037095
Contributors: Vikelis M; Rapoport AM
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine.

The journal of headache and pain
2016-09 | Journal article
DOI: 10.1186/s10194-016-0676-z
PMID: 27640152
PMC: PMC5026980
Contributors: Vikelis M; Argyriou AA; Dermitzakis EV; Spingos KC; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Photophobia in primary headaches, in essential blepharospasm and in major depression.

The International journal of neuroscience
2016-09 | Journal article
DOI: 10.1080/00207454.2016.1231185
PMID: 27580344
Contributors: Anagnostou E; Vikelis M; Tzavellas E; Ghika A; Kouzi I; Evdokimidis I; Kararizou E
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspective.

Therapeutic advances in neurological disorders
2015-07 | Journal article
DOI: 10.1177/1756285615585918
PMID: 26136843
PMC: PMC4480530
Contributors: Vikelis M; Spingos KC; Rapoport AM
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch.

SAGE Open Medicine
2015-06 | Journal article
DOI: 10.1177/2050312115587795
PMID: 26770787
PMC: PMC4679280
Contributors: Vagenas V; Vlachos GS; Vlachou N; Liakopoulos D; Kalaitzakis ME; Vikelis M
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).

PloS one
2014-11 | Journal article
DOI: 10.1371/journal.pone.0113933
PMID: 25419842
PMC: PMC4242657
Contributors: Hadjigeorgiou G; Dardiotis E; Tsivgoulis G; Doskas T; Petrou D; Makris N; Vlaikidis N; Thomaidis T; Kyritsis A; Fakas N et al.
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Sumatriptan iontophoretic transdermal system for the acute treatment of migraine.

Pain management
2014-03 | Journal article
DOI: 10.2217/pmt.13.71
PMID: 24641436
Contributors: Vikelis M; Mitsikostas DD; Rapoport AM
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine.

Neuropsychiatric disease and treatment
2012-09 | Journal article
DOI: 10.2147/NDT.S27456
PMID: 23055737
PMC: PMC3460671
Contributors: Vikelis M; Mitsikostas DD; Rapoport AM
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Depression in headaches: chronification.

Current opinion in neurology
2012-06 | Journal article
DOI: 10.1097/wco.0b013e328352c416
PMID: 22547099
Contributors: Deligianni CI; Vikelis M; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Headache in systemic lupus erythematosus vs multiple sclerosis: a prospective comparative study.

Headache
2011-07 | Journal article
DOI: 10.1111/j.1526-4610.2011.01962.x
PMID: 21797859
Contributors: Katsiari CG; Vikelis M; Paraskevopoulou ES; Sfikakis PP; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

New drug delivery options for migraine.

Expert review of neurotherapeutics
2011-06 | Journal article
DOI: 10.1586/ern.11.62
PMID: 21651323
Contributors: Vikelis M; Rapoport AM
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia.

Headache
2010-09 | Journal article
DOI: 10.1111/j.1526-4610.2010.01743.x
PMID: 21044281
Contributors: Mitsikostas DD; Pantes GV; Avramidis TG; Karageorgiou KE; Gatzonis SD; Stathis PG; Fili VA; Siatouni AD; Vikelis M
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Migraine recurrence is not associated with depressive or anxiety symptoms. Results of a randomized controlled trial.

Cephalalgia : an international journal of headache
2010-05 | Journal article
DOI: 10.1111/j.1468-2982.2009.02017.x
PMID: 20511208
Contributors: Mitsikostas DD; Vikelis M; Kodounis A; Zaglis D; Xifaras M; Doitsini S; Georgiadis G; Thomas A; Charmoussi S
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Role of antiepileptic drugs as preventive agents for migraine.

CNS drugs
2010-01 | Journal article
DOI: 10.2165/11310970-000000000-00000
PMID: 20030417
Contributors: Vikelis M; Rapoport AM
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Apraxia related with subcortical lesions due to cerebrovascular disease.

Acta neurologica Scandinavica
2009-12 | Journal article
DOI: 10.1111/j.1600-0404.2009.01224.x
PMID: 20028344
Contributors: Tabaki NE; Vikelis M; Besmertis L; Vemmos K; Stathis P; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2009-10 | Journal article
DOI: 10.1007/s10072-009-0170-3
PMID: 19876591
Contributors: Konstantopoulos K; Vikelis M; Seikel JA; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Elevated soluble intercellular adhesion molecule-1 levels are associated with poor short-term prognosis in middle-aged patients with acute ischaemic stroke.

International journal of cardiology
2008-01 | Journal article
DOI: 10.1016/j.ijcard.2007.11.031
PMID: 18191248
Contributors: Rallidis LS; Zolindaki MG; Vikelis M; Kaliva K; Papadopoulos C; Kremastinos DT
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.

Acta neurologica Scandinavica
2007-12 | Journal article
DOI: 10.1111/j.1600-0404.2007.00971.x
PMID: 18093263
Contributors: Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Refractory chronic headache associated with obstructive sleep apnoea syndrome.

Cephalalgia : an international journal of headache
2007-11 | Journal article
DOI: 10.1111/j.1468-2982.2007.01473.x
PMID: 17999682
Contributors: Mitsikostas DD; Vikelis M; Viskos A
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

The role of glutamate and its receptors in migraine.

CNS & neurological disorders drug targets
2007-08 | Journal article
DOI: 10.2174/187152707781387279
PMID: 17691981
Contributors: Vikelis M; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

A novel CADASIL-causing mutation in a stroke patient.

Swiss medical weekly
2007-06 | Journal article
DOI: 2007/21/smw-11816
PMID: 17629811
Contributors: Vikelis M; Papatriantafyllou J; Karageorgiou CE
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

CADASIL: a short review of the literature and a description of the first family from Greece.

Functional neurology
2006-04 | Journal article
PMID: 16796821
Contributors: Vikelis M; Xifaras M; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Inflammatory markers and in-hospital mortality in acute ischaemic stroke.

Atherosclerosis
2006-01 | Journal article
DOI: 10.1016/j.atherosclerosis.2005.11.032
PMID: 16388807
Contributors: Rallidis LS; Vikelis M; Panagiotakos DB; Rizos I; Zolindaki MG; Kaliva K; Kremastinos DT
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

SUNCT syndrome in the elderly.

Cephalalgia : an international journal of headache
2005-11 | Journal article
DOI: 10.1111/j.1468-2982.2005.00971.x
PMID: 16232162
Contributors: Vikelis M; Xifaras M; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Headache attributed to unruptured saccular aneurysm, mimicking hemicrania continua.

The journal of headache and pain
2005-05 | Journal article
DOI: 10.1007/s10194-005-0172-3
PMID: 16355298
PMC: PMC3451636
Contributors: Vikelis M; Xifaras M; Magoufis G; Gekas G; Mitsikostas DD
Source: Self-asserted source
Michail Vikelis via Europe PubMed Central

Peer review (1 review for 1 publication/grant)

Review activity for CNS drugs. (1)
How many people are using ORCID?